GSK has already moved on from its decision to drop a cancer asset on Tuesday by snagging a late-stage liver disease candidate ...

GSK has agreed to pay $1.2 billion upfront to acquire rights to efimosfermin from Cambridge, Massachusetts-based Boston ...

Just a day after dropping a $625m cancer asset, GSK has inked a deal worth a potential $2bn to acquire Boston Pharmaceuticals ...

TEL AVIV, IL / ACCESS Newswire / May 13, 2025 / Teva Pharmaceutical The Company achieved a 29% reduction in absolute scope 1 and 2 greenhouse gas emissions from 2019 levels, surpassing its target ...

Bonus Apr 19, 2024 Apr 20, 2024 Feb 29, 2024 Bonus Ratio: 3 share(s) for every 1 shares held Rights Feb 02, 2023 Feb 02, 2023 Aug 25, 2022 Rights ratio: 6 share for every 1 held at a price of Rs 20.0 ...

J B Chemicals & Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Export Incentives, Sale of services and Scrap for the year ending 31-Mar-2023.For ...